Dietary and Topical Magnesium Replacement or Supplementation in Patients With Lymphoma

EARLY_PHASE1RecruitingINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

April 15, 2022

Primary Completion Date

April 1, 2027

Study Completion Date

April 1, 2027

Conditions
Lymphoma
Interventions
DRUG

Magnesium Chloride-based Lotion

Given topically

OTHER

Quality-of-Life Assessment

Ancillary studies

BEHAVIORAL

Special Diet Therapy

Consume magnesium rich foods

Trial Locations (1)

55905

RECRUITING

Mayo Clinic in Rochester, Rochester

Sponsors

Lead Sponsor

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Mayo Clinic

OTHER

NCT05294367 - Dietary and Topical Magnesium Replacement or Supplementation in Patients With Lymphoma | Biotech Hunter | Biotech Hunter